Drugs Made In Stock Market Outlook
| DMII Stock | 10.01 0.01 0.10% |
Under 52% of Drugs Made's traders are presently thinking to get in. The analysis of overall sentiment of trading Drugs Made In stock suggests that some investors are interested at this time. Drugs Made's investing sentiment shows overall attitude of investors towards Drugs Made In.
Comfort Level 52
Impartial
Panic | Confidence |
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Drugs Made's input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Drugs Made In.
News SentimentBullish | Hype SentimentBearish | Insider SentimentWaiting |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Drugs Made In is 'Cautious Hold'. The recommendation algorithm takes into account all of Drugs Made's available fundamental, technical, and predictive indicators you will find on this site.
Execute Drugs Made Advice
The Drugs recommendation should be used to complement the investment advice compiled from the current analysts' consensus on Drugs Made In. Macroaxis does not own or have any residual interests in Drugs Made In or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Drugs Made's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Cautious Hold
Market Performance | Good | Details | |
Volatility | Very steady | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Barely shadows the market | Details | |
Investor Sentiment | Impartial | Details | |
Analyst Consensus | Not Available | Details | |
Financial Strenth (F Score) | Very Weak | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
For the selected time horizon Drugs Made In has a Mean Deviation of 0.0958, Standard Deviation of 0.142, Variance of 0.0202, Downside Variance of 0.0276, Semi Variance of (0.02) and Expected Short fall of (0.18)Our trade advice tool can cross-verify current analyst consensus on Drugs Made In and to analyze the company potential to grow in the current economic cycle. Please use Drugs Made shares outstanding and book value per share to make buy, hold, or sell decision on Drugs Made In. Given that Drugs Made In has a number of shares shorted of 85.98 K, we urge you to verify Drugs Made In market performance and probability of bankruptcy to ensure the company can sustain itself in the current economic cycle given your prevailing risk tolerance and investing horizon.
Drugs Made Trading Alerts and Improvement Suggestions
| Drugs Made In has a very weak financial position based on the latest SEC disclosures | |
| About 18.0% of the company shares are held by company insiders | |
| Latest headline from finance.yahoo.com: Fidium Introduces 8 Gig Fiber and WiFi 7 to Deliver True Multi-Gig Speeds to Every Device |
Drugs Made Returns Distribution Density
The distribution of Drugs Made's historical returns is an attempt to chart the uncertainty of Drugs Made's future price movements. The chart of the probability distribution of Drugs Made daily returns describes the distribution of returns around its average expected value. We use Drugs Made In price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Drugs Made returns is essential to provide solid investment analysis for Drugs Made.
| Mean Return | 0.02 | Value At Risk | -0.1 | Potential Upside | 0.30 | Standard Deviation | 0.14 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Drugs Made historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Drugs Made Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Drugs Made or Capital Markets sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Drugs Made's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Drugs stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 0.01 | |
β | Beta against Dow Jones | 0 | |
σ | Overall volatility | 0.14 | |
Ir | Information ratio | -0.16 |
Drugs Made Volatility Alert
Drugs Made In exhibits very low volatility with skewness of 0.73 and kurtosis of 3.59. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Drugs Made's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Drugs Made's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Drugs Made Fundamentals Vs Peers
Comparing Drugs Made's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Drugs Made's direct or indirect competition across all of the common fundamentals between Drugs Made and the related equities. This way, we can detect undervalued stocks with similar characteristics as Drugs Made or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Drugs Made's fundamental indicators could also be used in its relative valuation, which is a method of valuing Drugs Made by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Drugs Made to competition |
| Fundamentals | Drugs Made | Peer Average |
| Current Valuation | 655.39 M | 16.62 B |
| Shares Outstanding | 65.58 M | 571.82 M |
| Shares Owned By Insiders | 17.63 % | 10.09 % |
| Shares Owned By Institutions | 23.45 % | 39.21 % |
| Number Of Shares Shorted | 85.98 K | 4.71 M |
| Book Value Per Share | (0.26) X | 1.93 K |
| Short Ratio | 1.00 X | 4.00 X |
| Number Of Employees | 1 | 18.84 K |
| Market Capitalization | 655.09 M | 19.03 B |
Drugs Made Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Drugs . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Daily Balance Of Power | 9.2 T | |||
| Rate Of Daily Change | 1.0 | |||
| Day Median Price | 10.01 | |||
| Day Typical Price | 10.01 | |||
| Price Action Indicator | 0.005 | |||
| Period Momentum Indicator | 0.01 | |||
| Relative Strength Index | 60.8 |
About Drugs Made Buy or Sell Advice
When is the right time to buy or sell Drugs Made In? Buying financial instruments such as Drugs Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Drugs Made in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Exotic Funds Thematic Idea Now
Exotic Funds
Funds or Etfs with high minimum investment requirement that manage portfolios of alternative investments such as hedge funds, options, futures, real estate or commodities. The Exotic Funds theme has 43 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Exotic Funds Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Drugs Made Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Is there potential for Diversified Capital Markets market expansion? Will Drugs introduce new products? Factors like these will boost the valuation of Drugs Made. Projected growth potential of Drugs fundamentally drives upward valuation adjustments. Understanding fair value requires weighing current performance against future potential. All the valuation information about Drugs Made listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Drugs Made In's market price often diverges from its book value, the accounting figure shown on Drugs's balance sheet. Smart investors calculate Drugs Made's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Since Drugs Made's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
It's important to distinguish between Drugs Made's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Drugs Made should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. However, Drugs Made's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.